NCT06332469

Evaluation of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation

Feasibility Study of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation
Linkoeping University·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
Internet based education and support program for patients awaiting kidney transplantation
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Linkoeping University
Timeline & enrollment
Phase
N/A
Start date
Apr 08, 2024
End date
Oct 31, 2025
Enrollment
80 participants
Primary outcome

Kidney transplant understanding tool (K-TUT),Self-care in chronic illness inventory v.4c,The Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G,Pearlin Mastery Scale,The Depression Anxiety Stress Scales 21 (DASS-21),Acceptance of chronic health conditions scale (ACHC),EQ-5D-5L

Summary

The goal of this study is to test the feasibility study of an internet based education and
 support program for patients awaiting kidney transplantation. The study is designed as a
 national pilot randomized controlled trial with a waitlist control group, to test the
 feasibility, acceptability, and potential effects of the intervention on patients' physical
 and mental health.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06332469
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06332469 through Pure Global AI's free database. This phase not specified trial is sponsored by Linkoeping University and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.